AI Giants Team Up to Deliver Free Medical Decision Support to 100 Developing Nations
Anthropic and OpenEvidence are launching a global health equity initiative to bring evidence-based clinical tools to physicians in resource-limited settings across Africa, Asia, and Latin America.
Illustration: AI-generated
In a move that could reshape healthcare delivery in the world's most underserved regions, AI developer Anthropic and medical AI platform OpenEvidence have announced a partnership to provide free clinical decision support tools to healthcare providers in approximately 100 low- and middle-income countries. The initiative targets nations including Uganda, Angola, Sudan, Haiti, and Mongolia, where physicians often lack access to current medical literature, specialist consultation, and continuing education resources.
The collaboration builds on OpenEvidence's existing success in developed markets, where US clinicians alone consulted the platform 42 million times in August. According to the partnership announcement, several hundred million Americans are projected to be treated by doctors using OpenEvidence in 2025. The platform is currently available at no cost to clinicians in the United States and Europe.
Addressing Global Healthcare Disparities
The partnership aims to bridge a critical gap in global health equity. Healthcare providers in low- and middle-income countries frequently work without access to peer-reviewed journals, up-to-date treatment guidelines, or specialist networks that their counterparts in wealthy nations take for granted. By delivering evidence-based medical information through smartphone-accessible AI tools, the initiative seeks to democratize access to clinical knowledge even in areas without reliable electricity.
Dr. Ahmed Bendary, a cardiologist at Benha University in Egypt, represents the type of clinician the partnership hopes to support—physicians working in settings where current medical evidence can be difficult to obtain and apply.
Technical Adaptation for Local Contexts
The partnership divides responsibilities between the two companies: Anthropic provides the underlying AI infrastructure, while OpenEvidence tailors the system to regional healthcare realities. This customization is crucial, as medical AI developed for wealthy countries may not address the disease patterns, diagnostic capabilities, and treatment options available in resource-limited settings.
OpenEvidence is working with health organizations in Rwanda and Botswana to pilot and adapt its tools for local contexts. The smartphone-based access model is designed to function even in areas with intermittent power and limited internet connectivity, acknowledging the infrastructure challenges that define healthcare delivery in many target countries.
Unanswered Questions and Future Implications
While the partnership's scope is ambitious, key details remain undisclosed, including financial terms and specific metrics for measuring clinical impact. The initiative's success will likely depend on how effectively the AI tools can be adapted to address local disease burdens and available treatments, rather than simply translating Western medical protocols.
The collaboration may set a precedent for how AI companies approach global health equity, demonstrating a model where philanthropic goals drive expansion into markets that traditional business incentives alone would not reach. As OpenEvidence founder Daniel Nadler and Anthropic president Daniela Amodei roll out this initiative, the global health community will be watching to see whether AI-powered clinical decision support can meaningfully improve care quality in the world's most resource-constrained healthcare systems.
Sources
Companies in this article
Reporting & accountability
How we maintain accuracy
Health AI Central separates reported facts, analysis, and public-source data. Readers can review our standards, request a correction, or consult the relevant research methodology before relying on a claim.